A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

By | July 14, 2022
Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.